Evidence map›Paper›PMID 26085380›Full record

ArticleNature communications2015

Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours.

Young Chan Chae, Alessia Angelin, Sofia Lisanti, Andrew V Kossenkov, Kaye D Speicher, Huan Wang, James F Powers, Arthur S Tischler, Karel Pacak, Stephanie Fliedner and 6 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Young Chan Chae
Alessia Angelin
Sofia Lisanti
Andrew V Kossenkov
Kaye D Speicher
Huan Wang
James F Powers
Arthur S Tischler
Karel Pacak
Stephanie Fliedner
Ryan D Michalek
Edward D Karoly
Douglas C Wallace
Lucia R Languino
David W Speicher
Dario C Altieri

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Role of Runx2 in prostate tumorigenesis and metastasisP01CA140043 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2010 to 2021
$12.2M
MITOCHONDRIAL INBORN ERRORS OF METABOLISMR01NS021328 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 1985 to 2017
$6.5M
CONTROL OF APOPTOSIS IN CANCER BY SURVIVINR01CA078810 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 1998 to 2017
$5.5M
Molecular Pathology of Vascular InjuryR37HL054131 · NHLBI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2004 to 2013
$3.1M
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer AgentR01CA118005 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2009 to 2013
$1.7M
NCI NIH HHS P01 CA140043NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA078810NCI NIH HHS R01 CA118005NHLBI NIH HHS R37 HL054131NINDS NIH HHS R01 NS021328
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26085380
PMCPMC4750482

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.